Live Breaking News & Updates on Lotte biologics

Stay informed with the latest breaking news from Lotte biologics on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Lotte biologics and stay connected to the pulse of your community

Lotte sets up heath care unit in Japan

Lotte Holdings has launched a health care media platform in Japan in line with its strategic initiative to strengthen its foothold in the health care sector. Initially introduced as part of Lotte Group’s digital marketing efforts in 2020, Lotte transformed the platform into an independent media corporation on Feb. 1, now officially known as Lotte Medi Palette Co., Ltd. The health care platform is fully funded b...

Japan , Japanese , Lotte-biologics , Kyosuke-sakai , Lotte-holdings , Lotte , Lotte-medi-palette-co-ltd , Lotte-group , Lotte-group-chairman-shin-dong-bin , Lotte-medi-palette , Healthy-future-starts-here , Lotte-healthcare

Lotte sets up health care unit in Japan

Lotte Holdings has launched a health care media platform in Japan in line with its strategic initiative to strengthen its foothold in the health care sector. Initially introduced as part of Lotte Group’s digital marketing efforts in 2020, Lotte transformed the platform into an independent media corporation on Feb. 1, now officially known as Lotte Medi Palette Co., Ltd. The health care platform is fully funded b...

Japan , Japanese , Lotte-biologics , Kyosuke-sakai , Lotte , Lotte-group , Lotte-medi-palette-co-ltd , Lotte-holdings , Lotte-group-chairman-shin-dong-bin , Lotte-medi-palette , Healthy-future-starts-here , Lotte-healthcare

Biotechnology Contract Manufacturing Market Analysis by

Dublin, Feb. 14, 2024 (GLOBE NEWSWIRE) -- The

United-states , Dublin , Ireland , America , Biologics-cmos , Lotte-biologics , Samsung-biologics , Pharma-gmb , Polyplus-transfection , Abbvie-inc , Merck-kga , Collaborations-between-pharmaceutical-companies

Lotte to sell off 7-Eleven's ATM unit

As part of its business restructuring aims for this year, Lotte Group has decided to sell the ATM business of Korea Seven, formerly known as Lotte PSNet, which oversees the operation of the nation’s 7-Eleven convenience stores. According to Lotte Corp. on Wednesday, the group recently appointed accounting firm Samjeong KPMG to oversee the sale process and identify a suitable company to acquire Korea Seven'...

Samjeong , Kyonggi-do , South-korea , Japan , United-states , Vietnam , Republic-of , Vietnamese , Korea , Japanese , Shin-yoo-yeol , Lotte-psnet

Lotte chief eyes biotech, metaverse, hydrogen, batteries as new growth engines

Lotte Group will realign its business portfolio to focus on four major new growth engines - bio technology, metaverse, hydrogen energy and secondary batteries - and take preemptive steps to sell its non-core businesses to maximize management efficiency, Chairman Shin Dong-bin said.

Vietnam , Republic-of , Pakistan , Japan , Japanese , Shin-yoo-yeol , Yomiuri-shimbun , Lotte-biologics , Lotte , Lotte-group , Lotteria , Japan-to-zensho-holdings

LOTTE BIOLOGICS Announces Songdo Bio Plant Development Plan at JPM Healthcare Conference 2024

/PRNewswire/ -- LOTTE BIOLOGICS (CEO Richard Lee) announced its participation as a participating presenter on the Asia Pacific & Latin America (APAC&LatAm)...

San-francisco , California , United-states , Seoul , Soult-ukpyolsi , South-korea , Korea , Incheon-songdo , Asia-pacific-latin-america , Bristol-myers-squibb-syracuse , Richard-lee , Incheon-free-economic-zone-authority

[Herald Interview] Lotte Biologics' US plant to begin ADC services in early 2025

SAN FRANCISCO -- Lotte Biologics will begin production of its antibody-drug conjugates at its US plant by the first quarter of 2025, according to its CEO Richard Lee, who spoke at a meeting with reporters on Monday, held on the sidelines of the J.P. Morgan Healthcare Conference. As ADCs have emerged as a promising class of treatments, the Korean contract drug manufacturer has received a myriad of requests from potent...

Syracuse , New-york , United-states , Syracuse-university , South-korea , Korea , Incheon-songdo , Richard-lee , Lotte-biologics , Korea-polytechnic-university , Bristol-myers-squibb , Korea-ministry-of-food

Korean biotech firms flex muscles at J.P. Morgan Healthcare Conference

Korea Herald Correspondent SAN FRANCISCO -- A record number of Korean companies are set to deliver presentations to boast their latest biotechnologies at the 42nd J.P. Morgan Healthcare Conference, the largest event of its kind, which kicked off Monday in San Francisco. This year, the number of Korean companies that received official invitations from the host increased to six from three last year. The presenters incl...

San-francisco , California , United-states , South-korea , France , Korea , French , Seo-jung-jin , Songdo-incheon , Samsung-biologics , Lotte-biologics , Yuhan-corp

Lotte diversifies business portfolio to enhance customer experience

Lotte Group will invest 37 trillion won ($29 billion) over the next five years in health and wellness, mobility, sustainability and new life platform businesses while enhancing its competitiveness in retail, logistics and food sectors to lead innovation and provide differentiated customer experience, the conglomerate said Wednesday.

Incheon , Inch-on-gwangyoksi , South-korea , Busan , Pusan-gwangyoksi , Korea , Lotte-biologics , Society-of-cosmetic-scientists-korea , Lotte-group , Lotte-rd-center , Lotte-shopping-customer-fulfillment-center , Team-fresh

Lotte Biologics to begin ADC production in 2025

BARCELONA, Spain -- Lotte Biologics will begin antibody-drug conjugate manufacturing at its site near Syracuse, New York, starting in the first quarter of 2025, according to CEO Lee Won-jik, who also goes by Richard Lee. The company expects its ADC production to account for some 10 percent of its total sales in 10 years, Lee added. “Lotte Biologics is building an ADC facility within its Syracuse facilities. The...

Syracuse , New-york , United-states , Japan , Spain , Barcelona , Comunidad-autonoma-de-cataluna , China , Lotte-biologics , Songdo-incheon , Samsung-biologics , Richard-lee